Actively Recruiting

Phase Not Applicable
Age: 21Years - 85Years
All Genders
Healthy Volunteers
NCT05236348

Performance of the Aktiia Optical Blood Pressure Monitoring Device Against Double Auscultation

Led by Aktiia SA · Updated on 2024-08-19

225

Participants Needed

1

Research Sites

167 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study with N = 225 participants (1 cohort of a minimum of 85 and maximum of 140 participants, and an additional cohort with 85 participants) over 9 visits has been designed to assess the accuracy of Aktiia.product-us systolic and diastolic blood pressure measurements against double-auscultation reference measurements. In order to induce blood pressure changes and to simulate ambulatory scenarios, the study participants will be asked to perform a set of activities, involving body position changes and physical exercises. Additionally, this study will compare the heart rate measured by Aktiia.product-us against the reference readings provided by a finger pulse oximeter (as per ISO80601-2-61). The reliability of the auscultation readings will be controlled with simultaneous volume-clamp measurements.

CONDITIONS

Official Title

Performance of the Aktiia Optical Blood Pressure Monitoring Device Against Double Auscultation

Who Can Participate

Age: 21Years - 85Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult subjects aged between 21 and 85 years old
  • Subjects who can read and speak French
  • Subjects capable of performing simple physical exercises
  • Subjects willing to attend all 9 study visits
  • Subjects who have signed the informed consent form
Not Eligible

You will not qualify if you...

  • Clinical staff collaborating with the study principal investigator
  • Subjects with resting tachycardia (heart rate over 120 bpm)
  • Subjects diagnosed with atrial fibrillation
  • Subjects with diabetes
  • Subjects with renal dysfunctions
  • Subjects with hyper- or hypothyroidism
  • Subjects with pheochromocytoma
  • Subjects with Raynaud's disease
  • Subjects experiencing trembling or shivering
  • Subjects with interarm systolic blood pressure difference greater than 15 mmHg
  • Subjects with interarm diastolic blood pressure difference greater than 10 mmHg
  • Subjects with arm paralysis
  • Women known to be pregnant (for ARM 1 only)
  • Subjects with an arteriovenous fistula
  • Subjects with arm amputations
  • Subjects with upper arm circumference less than 22 cm or greater than 42 cm
  • Subjects with wrist circumference greater than 21 cm
  • Subjects with exfoliative skin diseases
  • Subjects with lymphoedema

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Lausanne Hospitals

Lausanne, Switzerland, 1011

Actively Recruiting

Loading map...

Research Team

J

Josep Sola, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here